Insurance companies could be required to cover asthma inhalers at no cost in New York state. Assemblywoman Jessica ...

According to GLOBOCAN 2022 data, lung cancer remains the fourth most common cause of cancer-related mortality in India.

SKF India Ltd clocked volume of 81867 shares by 10:48 IST on BSE, a 31.49 times surge over two-week average daily volume of 2600 shares. The stock gained 0.08% to Rs.5,385.25. Volumes stood at 1318 ...

The companies now plan on starting this year another large study of their drug, dapirolizumab pegol, in the hopes that they can confirm its safety and effectiveness to drug regulators.

Johnson & Johnson's stock has seen modest gains in recent months. Read why I downgrade JNJ stock from buy to hold.

This is to inform you that AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control ...

Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in ...

This summary covers various health news briefs including AstraZeneca's breast cancer drug trial results, a bird flu case in ...

The uptick in AstraZeneca share price came after the company announced that it has received permission to import for sale and ...

FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.

The greatest disparity in BC-specific survival was observed in women with HR+ HER2− tumors, with Black women having a 50% ...

The 13 drugs most likely to be chosen for CMS negotiations, according to the study: Ozempic, Rybelsus and Wegovy (semaglutide): Novo Nordisk's treatment for Type 2 diabetes and weight management.